<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Juvenile-Idiopathic-Arthritis on Rheumatology Digest</title><link>https://rheumatologydigest.org/tags/juvenile-idiopathic-arthritis/</link><description>Recent content in Juvenile-Idiopathic-Arthritis on Rheumatology Digest</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Mon, 07 Sep 2026 05:00:00 +0530</lastBuildDate><atom:link href="https://rheumatologydigest.org/tags/juvenile-idiopathic-arthritis/index.xml" rel="self" type="application/rss+xml"/><item><title>ITPA Activity and Methotrexate Response in JIA</title><link>https://rheumatologydigest.org/posts/itpa-activity-methotrexate-response-jia/</link><pubDate>Mon, 07 Sep 2026 05:00:00 +0530</pubDate><guid>https://rheumatologydigest.org/posts/itpa-activity-methotrexate-response-jia/</guid><description>A pre-treatment enzyme assay separates methotrexate responders from non-responders — but at 60% sensitivity it nudges a decision rather than making one.</description></item></channel></rss>